FDA DEVICE FACTS
iVitri Straw
Reprobitech Corp.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The iVitri® Straw is a cryopreservation storage device that is intended for use in vitrification procedures to contain and maintain human 4-8 cell and blastocyst stage embryos.
8. Comparison of Intended Use and Technological Characteristics of Subject and Predicate Devices: Parameter K172751 (subject device) K162640 (predicate device) Indications for Use Same as the predicate device The iVitri® EZ is a cryopreservation storage device that is intended for use in vitrification procedures to contain and maintain human 4-8 cell and blastocyst stage embryos. Fundamental design Same as the predicate device Consists of two components: a body with a tip, where the embryos are loaded, and a cap. The device is closed by surface friction of the body and cap. Body Same as the predicate device Consists of a single molded polystyrene stick that incorporates a curved sample loading area. Cap Weighted, straw-like cap Non-weighted, stick-like cap Dimensions Overall length: 130 mm Body length: 105 mm Cap length: 90 mm Tip length:16 mm Overall length: 130 mm Body length: 116 mm Cap length: 45.5 mm Tip length:16 mm Loading capacity Same as the predicate device Maximum of 3 embryos in ≤1 µl of medium Mode of action Same as the predicate device The device is closed prior to freezing in liquid nitrogen and opened during warming (i.e., the embryos have direct contact with warming media). Cooling rate -3,022C/min -3,020°C/min Warming rate +40,976°C/min +40,694°C/min Embryo contacting material Same as the predicate device Polystyrene including colorant (blue, orange, yellow, green, pink) The subject and predicate devices have the same Indications for Use, fundamental design, mode of action, material used in the embryo-contacting component, and embryo loading capacity. They also have comparable cooling and warming rates. There are differences in dimensions and design of the cap between the subject and predicate devices. However, these differences do not raise different questions of safety and effectiveness.
9. Non-Clinical Characteristics Performance Data: As part of demonstrating substantial equivalence to the predicate device, the following non-clinical performance tests were conducted. The iVitri® Straw passed all of the testing in accordance with internal requirements and applicable standards to support substantial equivalence of the subject device: Cooling/warming rate testing: The purpose of this testing was to evaluate the cooling and warming rates of the subject device. Temperature recording equipment was used to document the temperature profile of devices when used as prescribed in the Instructions for Use throughout the cooling and warming portions of the vitrification process. Results showed a cooling rate of -3,022oC/min, and a warming rate of +40,976oC/min. Durability and closure integrity testing: The purpose of this testing was to assess the integrity of the device following exposure to liquid nitrogen. The samples were assembled as described in the Instructions for Use and submerged in liquid nitrogen. The samples were then exposed to 37°C temperatures. Samples were then assessed for signs of leakage, damage (breaks, cracks, etc.), deformation or discoloration. The acceptance criteria were that devices must not exhibit any of the failure modes described above. Test samples met the acceptance criteria. Endotoxin testing per USP<85>: ≤0.5 EU/device Mouse Embryo Assay (MEA): 1-Cell mouse embryos were incubated in extracts of the subject device at 37C in an atmosphere containing 5% CO2. The percent of embryos developed to the expanded blastocyst stage at 96 hours were assessed in comparison with the control group. The acceptance criterion was 1-Cell MEA: ≥80% expanded blastocyst formation at 96 hours. Sterilization validation per ISO 11137-1:2006(R)2011 and ISO 11137-2:2013. Package integrity testing following accelerated aging per ASTM F1980-16: o Dye penetration testing per ASTM F929-15 o Seal strength testing per ASTM F88/F88M-15 Shelf-life studies (real-time and accelerated) were conducted to ensure that the following product specifications were met: o MEA o Durability and closure integrity testing o Device appearance (discoloration, deformation, damage) o Dimensional assessments
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。